Search Results - "PARAMESWARAN, Reshmi"

Refine Results
  1. 1

    A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers by Wong, Derek P., Roy, Nand K., Zhang, Keman, Anukanth, Anusha, Asthana, Abhishek, Shirkey-Son, Nicole J., Dunmire, Samantha, Jones, Bryan J., Lahr, Walker S., Webber, Beau R., Moriarity, Branden S., Caimi, Paolo, Parameswaran, Reshmi

    Published in Nature communications (11-01-2022)
    “…B cell-activating factor (BAFF) binds the three receptors BAFF-R, BCMA, and TACI, predominantly expressed on mature B cells. Almost all B cell cancers are…”
    Get full text
    Journal Article
  2. 2

    Repression of GSK3 restores NK cell cytotoxicity in AML patients by Parameswaran, Reshmi, Ramakrishnan, Parameswaran, Moreton, Stephen A., Xia, Zhiqiang, Hou, Yongchun, Lee, Dean A., Gupta, Kalpana, deLima, Marcos, Beck, Rose C., Wald, David N.

    Published in Nature communications (04-04-2016)
    “…Natural killer cells from acute myeloid leukaemia patients (AML-NK) show a dramatic impairment in cytotoxic activity. The exact reasons for this dysfunction…”
    Get full text
    Journal Article
  3. 3

    Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells by Feinberg, Daniel, Ramakrishnan, Parameswaran, Wong, Derek P, Asthana, Abhishek, Parameswaran, Reshmi

    Published in Frontiers in immunology (11-04-2022)
    “…Natural killer (NK) cells mediate killing of malignant and virus-infected cells, a property that is explored as a cell therapy approach in the clinic. Various…”
    Get full text
    Journal Article
  4. 4

    Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia by Ryva, Bradley, Zhang, Keman, Asthana, Abhishek, Wong, Derek, Vicioso, Yorleny, Parameswaran, Reshmi

    Published in Frontiers in oncology (21-02-2019)
    “…Dietary lectins are carbohydrate-binding proteins found in food sources. We used a panel of seven dietary lectins to analyze cytotoxicity against hematological…”
    Get full text
    Journal Article
  5. 5

    NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells by Vicioso, Yorleny, Wong, Derek P, Roy, Nand K, Das, Nayanika, Zhang, Keman, Ramakrishnan, Parameswaran, Parameswaran, Reshmi

    Published in Frontiers in immunology (29-04-2021)
    “…Natural Killer (NK) cells are cytotoxic lymphocytes critical to the innate immune system. We found that germline deficiency of NF-κB c-Rel results in a marked…”
    Get full text
    Journal Article
  6. 6
  7. 7

    BAFF receptor antibody for mantle cell lymphoma therapy by Zhang, Keman, Roy, Nand K, Vicioso, Yorleny, Woo, Janghee, Beck, Rose, de Lima, Marcos, Caimi, Paolo, Feinberg, Daniel, Parameswaran, Reshmi

    Published in Oncoimmunology (01-01-2021)
    “…Mantle cell lymphoma (MCL) is an aggressive form of B cell non-Hodgkin's lymphoma and remains incurable under current treatment modalities. One of the main…”
    Get full text
    Journal Article
  8. 8

    A Functional Receptor for B-Cell-Activating Factor Is Expressed on Human Acute Lymphoblastic Leukemias by PARAMESWARAN, Reshmi, MÜSCHEN, Markus, KIM, Yong-Mi, GROFFEN, John, HEISTERKAMP, Nora

    Published in Cancer research (Chicago, Ill.) (01-06-2010)
    “…B-lineage acute lymphoblastic leukemia (ALL) arises by transformation of a progenitor (pre-B) cell. Cure rates in adults remain low and treatment is…”
    Get full text
    Journal Article
  9. 9

    O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia by Parameswaran, Reshmi, Lim, Min, Arutyunyan, Anna, Abdel-Azim, Hisham, Hurtz, Christian, Lau, Kam, Müschen, Markus, Yu, Robert K, von Itzstein, Mark, Heisterkamp, Nora, Groffen, John

    Published in The Journal of experimental medicine (08-04-2013)
    “…The development of resistance to chemotherapy is a major cause of relapse in acute lymphoblastic leukemia (ALL). Though several mechanisms associated with drug…”
    Get full text
    Journal Article
  10. 10

    The role of Cdk5/p35 kinase activity in natural killer cell cytotoxicity by Wong, Derek P, Parameswaran, Reshmi

    Published in The Journal of immunology (1950) (01-05-2022)
    “…Abstract Natural killer (NK) cells and T cells are immune cells with cytotoxic function, but while the distinct role of Cyclin-dependent kinase 5 (Cdk5) in the…”
    Get full text
    Journal Article
  11. 11

    Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death by Asthana, Abhishek, Ramakrishnan, Parameswaran, Vicioso, Yorleny, Zhang, Keman, Parameswaran, Reshmi

    Published in Molecular cancer therapeutics (01-10-2018)
    “…Treatment for acute myeloid leukemia (AML) has remained unchanged for past 40 years. Targeting cell metabolism is a promising avenue for future cancer therapy…”
    Get full text
    Journal Article
  12. 12

    Activin β A in term placenta and its correlation with placental inflammation in parturients having epidural or systemic meperidine analgesia: a randomized study by Evron, Shmuel, MD, Parameswaran, Reshmi, PhD, Zipori, Dov, PhD, Ezri, Tiberiu, MD, Sadan, Oscar, MD, Koren, Rumelia, MD

    Published in Journal of clinical anesthesia (01-05-2007)
    “…Abstract Study Objective To investigate the immunohistochemical localization of β A subunit of activin A in human term placenta, as a marker for placental…”
    Get full text
    Journal Article
  13. 13

    The Mesenchymal Stroma Negatively Regulates B Cell Lymphopoiesis through the Expression of Activin A by SHOHAM, TSIPI, PARAMESWARAN, RESHMI, SHAV-TAL, YARON, BARDA-SAAD, MIRA, ZIPORI, DOV

    Published in Annals of the New York Academy of Sciences (01-05-2003)
    “…: The negative control of B cell generation is only partially resolved. We assessed the role of activin A in regulation of B lymphopoiesis in view of its…”
    Get full text
    Journal Article
  14. 14

    Ligand Based CAR T-Cell Targeting BAFF Receptors Asa Novel Therapy for B Cell Malignancies by Parameswaran, Reshmi, Wong, Derek, Zhang, Keman, Asthana, Abhishek, de Lima, Marcos, Caimi, Paolo F

    Published in Blood (05-11-2020)
    “…Background: Autologous T cells engineered to express chimeric antigen receptors (CARs) targeting CD19 have shown rapid and durable responses in B cell…”
    Get full text
    Journal Article
  15. 15

    The mesenchyme expresses T cell receptor mRNAs: relevance to cell growth control by BARDA-SAAD, Mira, SHAV-TAL, Yaron, ZIPORI, Dov, ROZENSZAJN, Arie Leon, COHEN, Michal, ZAUBERMAN, Ayelet, KARMAZYN, Asaf, PARAMESWARAN, Reshmi, SCHORI, Hadas, ASHUSH, Hagit, BEN-NUN, Avraham

    Published in Oncogene (21-03-2002)
    “…The mesenchyme plays a crucial regulatory role in organ formation and maintenance. However, comprehensive molecular characterization of these cells is lacking…”
    Get full text
    Journal Article
  16. 16

    A new Natural Killer cell therapy to target relapse Acute Lymphoblastic Leukemia by Vicioso, Yorleny M, Beck, Rose, Gram, Herman, Zhang, Keman, Asthana, Abhishek, Wong, Derek, Letterio, John, Parameswaran, Reshmi

    Published in The Journal of immunology (1950) (01-05-2020)
    “…Abstract Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Drug resistance and relapse are two major problems in ALL. Pre-B ALL cells…”
    Get full text
    Journal Article
  17. 17

    Abstract 2696: PPAR beta/delta is a novel therapeutic target in acute myeloid leukemia by Hu, Sophia, Wald, David, Parameswaran, Reshmi

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Abstract Acute myeloid leukemia (AML) is characterized by the differentiation arrest and rapid proliferation of abnormal white blood cells. Current…”
    Get full text
    Journal Article
  18. 18

    Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice by Ramakrishnan, Parameswaran, Yui, Mary A, Tomalka, Jeffrey A, Majumdar, Devdoot, Parameswaran, Reshmi, Baltimore, David

    Published in Diabetes (New York, N.Y.) (01-08-2016)
    “…The nuclear factor-κB protein c-Rel plays a critical role in controlling autoimmunity. c-Rel-deficient mice are resistant to streptozotocin-induced diabetes, a…”
    Get full text
    Journal Article
  19. 19

    Abstract 3186: A novel combination therapy for treating advanced drug resistant acute lymphoblastic leukemia by Vicioso, Yorleny M., Beck, Rose, Gram, Herman, Asthana, Abhishek, Zhang, keman, Wong, Derek, Letterio, John, Parameswaran, Reshmi

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Purpose: Drug resistance and relapse are two major problems in Acute Lymphoblastic Leukemia (ALL) as these patients do not respond to chemotherapy. We…”
    Get full text
    Journal Article
  20. 20

    Deficiency of Nuclear Factor-[kappa]B c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice by Ramakrishnan, Parameswaran, Yui, Mary A, Tomalka, Jeffrey A, Majumdar, Devdoot, Parameswaran, Reshmi, Baltimore, David

    Published in Diabetes (New York, N.Y.) (01-08-2016)
    “…The nuclear factor-...B protein c-Rel plays a critical role in controlling autoimmunity. c-Rel-deficient mice are resistant to streptozotocin-induced diabetes,…”
    Get full text
    Journal Article